NCT04222712View on ClinicalTrials.gov

A Study to Evaluate TRS01 Eye Drops in Participants With Active Non-infectious Anterior Uveitis

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

16

Participants

Timeline

Start Date

February 1, 2020

Primary Completion Date

August 24, 2020

Study Completion Date

August 24, 2020

Conditions

Non-infectious Anterior Uveitis

Interventions

DRUG

TRS01 eye drops

Dosed four times a day (QID)

DRUG

TRS01 eye drops

Dosed four times a day (QID)

Trial Locations (2)

78240

San Antonio, San Antonio

07650

Palisades Park, Palisades Park

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Tarsier Pharma

INDUSTRY